EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study

Johanna Melin iD, Elina Holopainen, Hanna Savolainen-Peltonen

Cancer Medicine · 2024

DOI: 10.1002/cam4.7034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Johanna Melin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Fertility Preservation, Breast Neoplasms, Infertility. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Academy of Finland, The Medical Society of Finland, The Finnish State Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Advances in multimodality cancer treatments have increased long‐term survival rates for early onset cancer patients, with 5‐year survival rates reaching 80% in Northern Europe. According to recent recommendations, clinicians should, as early as possible, inform cancer patients about the impact that cancer treatment may have on their fertility. Still, there is limited published data on fertility counselling (FC) and fertility preservation (FP) for cancer patients.

Methods

This register‐based study used hospital records to identify female cancer patients in the hospital district ( n = 192) who received FC at the age of 16–42 years between 2011 and 2019.

Results

Altogether, 97 (50.5%) cancer patients were eligible for FP. Of these, 55 (56.7%) underwent FP, whereas 42 (43.3%) declined. Women undergoing FP were recommended cancer treatments with a higher risk of infertility ( p = 0.01), and women with breast cancer were more prone to undergo FP than women with lymphoma ( p = 0.043). In FP treatment cycles, the mean number of oocytes retrieved (13.9 ± 7.7 vs. 12.0 ± 6.5, p = 0.04) and transferrable embryos (4.7 ± 2.9 vs. 3.7 ± 2.8, p = 0.002) was higher among cancer patients compared to age‐matched comparisons with male or tubal factor infertility. The total mean gonadotropin dose used was higher among cancer patients (2243 ± 963 IU vs. 1679 ± 765 IU, p < 0.001).

Conclusion

We conclude that a good ovarian response during FP can be achieved in female cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationBreast NeoplasmsInfertilityHumansFemaleMaleAdolescentYoung AdultAdultCryopreservationFinlandCounselingRetrospective Studies

Stichwörter der Autor:innen

controlled ovarian hyperstimulationembryo cryopreservationfemale cancer patientsfertility counsellingfertility preservationoocyte cryopreservation

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

ORCID-Profile: Johanna Melin

Förderung

  • The Academy of Finland
  • The Medical Society of Finland
  • The Finnish State Research Funding

Zitieren

APA

Melin, J., Holopainen, E., & Savolainen-Peltonen, H. (2024). Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study. Cancer Medicine. https://doi.org/10.1002/cam4.7034

Vancouver

Melin J, Holopainen E, Savolainen-Peltonen H. Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study. Cancer Medicine. 2024. doi:10.1002/cam4.7034

BibTeX
@article{Melin2024,
  author = {Melin, Johanna and Holopainen, Elina and Savolainen-Peltonen, Hanna},
  title = {Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7034}
}
Kostenlos starten →